- Naranj Research Desk
- 🇸🇦 Saudi Stock Market
- 🇺🇸 USA Stock Market
4% – 6%
12 - 14 Days
4% – 6%
12 - 14 Days
| Metric | Q1 FY26 (Mar '26) | Q4 FY25 (Dec '25) | Q1 FY25 (Mar '25) | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Total Revenue | $4,647 M | $2,805 M | $3,046 M | ▲ 65.7% | ▲ 52.6% |
| Adjusted EBITDA | $727.1 M | $(307.8) M | $328.8 M | ▲ N/M (turnaround) | ▲ 121.1% |
| Operating Margin | 15.20% | -11.90% | 9.80% | ▲ 2,710 bps | ▲ 540 bps |
| Net Income (PAT) | $679.0 M | $(352.6) M | $275.3 M | ▲ N/M (turnaround) | ▲ 146.6% |
| Diluted EPS | $2.07 | $(1.24) | $0.92 | ▲ N/M (turnaround) | ▲ 125.0% |
OSCR — NYSE —
| EMA | Value | Stock Position |
|---|---|---|
| 5 EMA | 23.63 | Above |
| 10 EMA | 22.35 | Above |
| 20 EMA | 20.24 | Above |
| 50 EMA | 17.53 | Above |
| 100 EMA | 16.43 | Above |
| 200 EMA | 16.00 | Above |
| EMA | Value | Stock Position |
|---|---|---|
| 5 EMA | 23.63 | Above |
| 10 EMA | 22.35 | Above |
| 20 EMA | 20.24 | Above |
| 50 EMA | 17.53 | Above |
| 100 EMA | 16.43 | Above |
| 200 EMA | 16.00 | Above |
Based on our positional trading picks in USA stocks, Oscar Health stock price target will be USD 26 - USD 27 in the next 12-14 trading sessions.
4% – 6%
12 - 14 Days
4% – 6%
12 - 14 Days
Oscar Health, Inc. is a U.S.-based healthcare technology company that provides health insurance plans for individuals, families, employees, and small businesses. It also offers technology platforms, provider engagement tools, reinsurance products, and online enrollment services for brokers and customers. Founded in 2012, the company is headquartered in New York.
| Metric | Q1 FY26 (Mar '26) | Q4 FY25 (Dec '25) | Q1 FY25 (Mar '25) | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Total Revenue | $4,647 M | $2,805 M | $3,046 M | ▲ 65.7% | ▲ 52.6% |
| Adjusted EBITDA | $727.1 M | $(307.8) M | $328.8 M | ▲ N/M (turnaround) | ▲ 121.1% |
| Operating Margin | 15.20% | -11.90% | 9.80% | ▲ 2,710 bps | ▲ 540 bps |
| Net Income (PAT) | $679.0 M | $(352.6) M | $275.3 M | ▲ N/M (turnaround) | ▲ 146.6% |
| Diluted EPS | $2.07 | $(1.24) | $0.92 | ▲ N/M (turnaround) | ▲ 125.0% |
OSCR — NYSE —
| EMA | Value | Stock Position |
|---|---|---|
| 5 EMA | 23.63 | Above |
| 10 EMA | 22.35 | Above |
| 20 EMA | 20.24 | Above |
| 50 EMA | 17.53 | Above |
| 100 EMA | 16.43 | Above |
| 200 EMA | 16.00 | Above |
| EMA | Value | Stock Position |
|---|---|---|
| 5 EMA | 23.63 | Above |
| 10 EMA | 22.35 | Above |
| 20 EMA | 20.24 | Above |
| 50 EMA | 17.53 | Above |
| 100 EMA | 16.43 | Above |
| 200 EMA | 16.00 | Above |
Based on our positional trading picks in USA stocks, Oscar Health stock price target will be USD 26 - USD 27 in the next 12-14 trading sessions.
Arijit Banerjee CMT CFTe is a seasoned expert in the financial industry, boasting decades of experience in trading, investment, and wealth management. As the founder and chief strategist of Naranj Capital, he’s built a reputation for providing insightful research analysis to guide investment decisions.
Arijit’s credentials are impressive, holding both the Chartered Market Technician (CMT) and Certified Financial Technician (CFTe) designations. These certifications demonstrate his expertise in technical analysis and financial markets.
Through Naranj Capital, Arijit shares his market insights and research analysis, offering actionable advice for investors. His work is featured on platforms like TradingView, where he publishes detailed analysis and recommendations.
If you’re interested in learning more about Arijit’s work or Naranj Capital’s services, you can reach out to them directly through their website
